Farnesoid X Receptor Agonist INT-767 Attenuates Liver Steatosis and Inflammation in Rat Model of Nonalcoholic Steatohepatitis

Drug Design, Development and Therapy- New Zealand

doi 10.2147/dddt.s170518

Full Text

Abstract

Available in

Date

Authors

Publisher

Informa UK Limited

Related search

MicroRNA-155 Deficiency Attenuates Liver Steatosis and Fibrosis Without Reducing Inflammation in a Mouse Model of Steatohepatitis

PLoS ONE
Multidisciplinary
2015English

A Novel Inhibitor of Stearoyl-CoA Desaturase-1 Attenuates Hepatic Lipid Accumulation, Liver Injury and Inflammation in Model of Nonalcoholic Steatohepatitis

Biological and Pharmaceutical Bulletin
MedicinePharmacologyPharmaceutical Science
2013English

A Retinoid X Receptor Partial Agonist Attenuates Pulmonary Emphysema and Airway Inflammation

Respiratory Research
PulmonaryRespiratory Medicine
2019English

Myricetin Modulates Macrophage Polarization and Mitigates Liver Inflammation and Fibrosis in a Murine Model of Nonalcoholic Steatohepatitis

Frontiers in Medicine
Medicine
2020English

Inhibition of Plasminogen Activator Inhibitor 1 Attenuates Hepatic Steatosis but Does Not Prevent Progressive Nonalcoholic Steatohepatitis in Mice

Hepatology Communications
Hepatology
2018English

Emerging Treatments for Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis

Clinics in Liver Disease
Hepatology
2018English

Nonalcoholic Steatohepatitis in Posttransplantation Liver: Review Article

Revista da Associacao Medica Brasileira
Medicine
2018English

Targeting the Mitochondrial Pyruvate Carrier Attenuates Fibrosis in a Mouse Model of Nonalcoholic Steatohepatitis

Hepatology
MedicineHepatology
2017English

The Riddle of Nonalcoholic Fatty Liver Disease: Progression From Nonalcoholic Fatty Liver to Nonalcoholic Steatohepatitis

Journal of Clinical and Experimental Hepatology
Hepatology
2015English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2026 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy